Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Covington
Accenture
AstraZeneca
Express Scripts
UBS
Farmers Insurance
Daiichi Sankyo
Federal Trade Commission

Generated: January 19, 2018

DrugPatentWatch Database Preview

CEFPIRAMIDE SODIUM Drug Profile

« Back to Dashboard

Which patents cover Cefpiramide Sodium, and what generic alternatives are available?

Cefpiramide Sodium is a drug marketed by Wyeth Ayerst and is included in one NDA.

The generic ingredient in CEFPIRAMIDE SODIUM is cefpiramide sodium. There is one drug master file entry for this compound. Additional details are available on the cefpiramide sodium profile page.
Summary for CEFPIRAMIDE SODIUM
Drug patent expirations by year for CEFPIRAMIDE SODIUM

US Patents and Regulatory Information for CEFPIRAMIDE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst CEFPIRAMIDE SODIUM cefpiramide sodium INJECTABLE;INJECTION 050633-002 Jan 31, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Ayerst CEFPIRAMIDE SODIUM cefpiramide sodium INJECTABLE;INJECTION 050633-003 Jan 31, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Ayerst CEFPIRAMIDE SODIUM cefpiramide sodium INJECTABLE;INJECTION 050633-005 Jan 31, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cantor Fitzgerald
US Army
McKesson
Chinese Patent Office
Medtronic
Harvard Business School
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot